These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Current problems in drug research]. Nuhn P Pharmazie; 1985 Jan; 40(1):1-9. PubMed ID: 3887436 [No Abstract] [Full Text] [Related]
3. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs. Garrett ER Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331 [No Abstract] [Full Text] [Related]
4. [Significance of biopharmaceutics for practical drug therapy]. Dettli L Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:57-63. PubMed ID: 5288609 [No Abstract] [Full Text] [Related]
5. [Effect of chemical structure on the biological activity of pharmaceutical drugs]. MachoĊ Z Postepy Hig Med Dosw; 1972; 26(6):773-91. PubMed ID: 4671371 [No Abstract] [Full Text] [Related]
6. FUNCTION OF THE USAN COUNCIL. JEROME JB Am J Pharm Sci Support Public Health; 1964; 136():107-13. PubMed ID: 14167235 [No Abstract] [Full Text] [Related]
7. Development of quality control methodology for new drugs. Wagner RL Bull Parenter Drug Assoc; 1972; 26(2):76-86. PubMed ID: 5012206 [No Abstract] [Full Text] [Related]
8. Bioavailability, clinical effectiveness, and the public interest. Levy G Pharmacology; 1972; 8(1):33-43. PubMed ID: 4644654 [No Abstract] [Full Text] [Related]
9. [Significance of new effective-substances for basic research]. Kobinger W Subsid Med; 1975; 1-2():13-5. PubMed ID: 1114844 [No Abstract] [Full Text] [Related]
10. [Phase I studies on healthy test subjects and patients]. Zapf RM; Rupp W Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1638-40. PubMed ID: 4205543 [No Abstract] [Full Text] [Related]
11. Personal adventures in biopharmaceutical research during the 1953-1984 years. Swintosky JV Drug Intell Clin Pharm; 1985 Apr; 19(4):265-76. PubMed ID: 3891277 [No Abstract] [Full Text] [Related]
13. Aspects of pharmacokinetics and biopharmaceutics in relation to drug activity. Wagner JG Am J Pharm Sci Support Public Health; 1969; 141(1):5-20. PubMed ID: 5776857 [No Abstract] [Full Text] [Related]
14. [A pharmacokinetic function for galenics]. Dost FH Arzneimittelforschung; 1971 May; 21(5):712-7. PubMed ID: 5109699 [No Abstract] [Full Text] [Related]
15. Strategies to improve oral drug bioavailability. Gomez-Orellana I Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics as a basic pharmacological problem]. Dettli L Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():59-73. PubMed ID: 4906026 [No Abstract] [Full Text] [Related]
17. [Research of for the discovery of new drugs and research for the development and production of drugs]. Setnikar I Boll Chim Farm; 1971 Sep; 110(9):503-9. PubMed ID: 5137987 [No Abstract] [Full Text] [Related]
18. Assuring total drug quality. Simmons HE J Am Pharm Assoc; 1973 Feb; 13(2):96-8. PubMed ID: 4686621 [No Abstract] [Full Text] [Related]
19. A product standards form for new radipharmaceuticals. Warbick A Am J Hosp Pharm; 1974 Feb; 31(2):165-6. PubMed ID: 4815850 [No Abstract] [Full Text] [Related]
20. Letter: Generic versus brand names. J Indian Med Assoc; 1974 May; 62(10):361-3. PubMed ID: 4430845 [No Abstract] [Full Text] [Related] [Next] [New Search]